The announcement comes less than one month after a judge’s ruling opened the door to thousands of lawsuits against the multinational medical and CPG company; but Johnson & Johnson attributes the decision to a COVID-19 portfolio assessment.
The luxury house has filed suit against a Brooklyn-based knock off scents manufacturer as it believes it has violated the copyright of its' ‘Prada Candy’ fragrance.
